Stress versus depression - PubMed (original) (raw)
Review
Stress versus depression
F Lechin et al. Prog Neuropsychopharmacol Biol Psychiatry. 1996 Aug.
Abstract
1. Exhaustive evidence is quoted showing that uncontrollable (uncoping) stress provoked in experimental mammals leads to depletion of central noradrenergic activity+ adrenomedullary-cortical gland hyperactivity. These physiological disorders cause the typical neuroendocrine peripheral profile: a) raised catecholamines (CA) in plasma [noradrenaline (NA)+adrenaline (Ad)+dopamine (DA), b) reduced NA/Ad ratio in plasma and c) raised plasma cortisol. 2. Exhaustive evidence is quoted which indicates that severely ill humans show peripheral neuroendocrine profile similar to that found in mammals submitted to uncontrollable stress situation. Further, the NA/Ad ratio does not increase but decreases during orthostasis and exercise stress challenges, as well as oral glucose stress (tolerance) test. 3. Exhaustive evidence is quoted which indicates that endogenous depressed subjects show a neuroendocrine profile opposite to that observed in stressed mammals and severely ill humans. This profile consists of central NA (neural sympathetic) hyperactivity+ adrenomedullary glands hyporresponsivity. These disorders are reflected in a three to ten fold increase of the NA/Ad ratio in plasma. 4. Exhaustive evidence is also quoted showing that dysthymic depressed patients show low plasma catecholamines+low NA/Ad plasma ratio (< 2) during supine-resting condition, it is normalized at orthostasis and exercise periods. 5. It is quoted evidence showing that whereas platelet serotonin is increased in dysthymics, the same is reduced in both endogenous depressed and stressed mammals as well as severely ill humans. 6. It is quoted evidence showing that free serotonin in plasma is greatly raised in uncoping stressed mammals and severely ill humans. The same parameter is normal or slightly increased in dysthymic and endogenous depressed humans. These findings are consistent with the increased platelet aggregability observed in "uncontrollable" stressed mammals and in severely ill, but not depressed patients. 7. It is also quoted evidence showing that whereas parasympathetic activity is absent in uncontrollable stressed mammals and severely ill humans, the same is increased in both types of depressed humans. 8. According to the above, the authors postulate the existence of 3 distinct central+ peripheral neuroendocrine profiles for endogenous depression, dysthymic depression and maladaptation to stress syndrome. These different profiles should lead researchers to attempt different therapeutical approach. 9. In view of the fact that the authors found much clinical overlap among the three syndromes (endogenous depression, dysthymic depression and severely ill patients), they believe that a differential diagnosis should be based on neurochemical, neuroendocrine, physiologic, metabolic and neuropharmacological grounds. 10. The experimentally induced uncontrollable stress (behavioral despair) syndrome in mammals should not be used as a valid model of human depressive syndrome.
Similar articles
- Plasma neurotransmitters, blood pressure and heart rate during supine resting, orthostasis and moderate exercise in severely ill patients: a model of failing to cope with stress.
Lechin F, van der Dijs B, Orozco B, Lechin AE, Baez S, Lechin ME, Benaim M, Acosta E, Arocha L, Jimenez V, Leon G, Garcia Z. Lechin F, et al. Psychother Psychosom. 1996;65(3):129-36. doi: 10.1159/000289064. Psychother Psychosom. 1996. PMID: 8784943 - Insulin versus glucagon crosstalk: central plus peripheral mechanisms.
Lechin F, Dijs Bv, Pardey-Maldonado B. Lechin F, et al. Am J Ther. 2013 Jul-Aug;20(4):349-62. doi: 10.1097/MJT.0b013e318235f295. Am J Ther. 2013. PMID: 23838633 - Plasma neurotransmitters, blood pressure, and heart rate during supine resting, orthostasis, and moderate exercise in dysthymic depressed patients.
Lechin F, van der Dijs B, Orozco B, Lechin AE, Báez S, Lechin ME, Rada I, Acosta E, Arocha L, Jiménez V, et al. Lechin F, et al. Biol Psychiatry. 1995 Jun 15;37(12):884-91. doi: 10.1016/0006-3223(94)00220-w. Biol Psychiatry. 1995. PMID: 7548463 Clinical Trial. - Benzodiazepines: tolerability in elderly patients.
Lechin F, van der Dijs B, Benaim M. Lechin F, et al. Psychother Psychosom. 1996;65(4):171-82. doi: 10.1159/000289072. Psychother Psychosom. 1996. PMID: 8843497 Review. - Stress and brain noradrenaline: a review.
Glavin GB. Glavin GB. Neurosci Biobehav Rev. 1985 Summer;9(2):233-43. doi: 10.1016/0149-7634(85)90048-x. Neurosci Biobehav Rev. 1985. PMID: 2861590 Review.
Cited by
- Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.
Licznerski P, Duman RS. Licznerski P, et al. Neuroscience. 2013 Oct 22;251:33-50. doi: 10.1016/j.neuroscience.2012.09.057. Epub 2012 Oct 2. Neuroscience. 2013. PMID: 23036622 Free PMC article. Review. - Serum Serotonin Abnormality in Depression.
Saldanha D, Kumar N, Ryali V, Srivastava K, Pawar AA. Saldanha D, et al. Med J Armed Forces India. 2009 Apr;65(2):108-12. doi: 10.1016/S0377-1237(09)80120-2. Epub 2011 Jul 21. Med J Armed Forces India. 2009. PMID: 27408213 Free PMC article. - The pain, depression, and fatigue symptom cluster in advanced breast cancer: covariation with the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system.
Thornton LM, Andersen BL, Blakely WP. Thornton LM, et al. Health Psychol. 2010 May;29(3):333-7. doi: 10.1037/a0018836. Health Psychol. 2010. PMID: 20496988 Free PMC article. - Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target.
Giatti S, Di Domizio A, Diviccaro S, Falvo E, Caruso D, Contini A, Melcangi RC. Giatti S, et al. J Med Chem. 2021 Apr 22;64(8):4553-4566. doi: 10.1021/acs.jmedchem.0c02039. Epub 2021 Apr 12. J Med Chem. 2021. PMID: 33843213 Free PMC article. - Crossroads of corticotropin releasing hormone, corticosteroids and monoamines. About a biological interface between stress and depression.
Van Praag HM. Van Praag HM. Neurotox Res. 2002 Aug-Sep;4(5-6):531-555. doi: 10.1080/1029842021000022115. Neurotox Res. 2002. PMID: 12754165
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources